Rentschler Biotechnologie Expands Single-Use Capabilities
PTSM: Pharmaceutical Technology Sourcing and Management
Rentschler Biotechnologie expands European manufacturing capabilities with GE Healthcare Life Sciences bioprocess technologies.
GE Healthcare Life Sciences and Rentschler Biotechnologie GmbH have announced the handover of GE Healthcare’s 1000th ÄKTAprocess and the expansion of Rentschler’s biopharmaceutical manufacturing capabilities in Laupheim, Germany.
ÄKTAprocess, GE’s automated process and manufacturing scale chromatography system, has gone into operation as part of Rentschler’s recently expanded single-use manufacturing suite. Other GE biomanufacturing technologies, such as the XDR 2000-L bioreactor, and seed trains of 50 L, 200 L and 500 L are featured in Rentschler’s single-use manufacturing line.â¨â¨
Source: Rentschler Biotechnologie GmbH
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
